Suchergebnisse - "Gaibani, Paolo"

PubPharm (147)

1

Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment

enthalten in: International journal of antimicrobial agents | 2024

von Amadesi, S. | Gatti, M. | Rinaldi, M. | +3

2

Complete genome sequence of invasive Streptococcus pneumoniae serotype 11A causing meningitis in an adult patient, Italy 2022

enthalten in: Microbiology resource announcements | 2024

von Amadesi, S. | Vocale, C. | Guariglia, D. | +4

3

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

enthalten in: Microbiology spectrum | 2024

von Santerre Henriksen, A. | Jeannot, K. | Oliver, A. | +55

4

Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2024

von Bianco, G. | Boattini, M. | Comini, S. | +3

5

Performance evaluation of Bruker $ UMIC^{®} $ microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species

enthalten in: European journal of clinical microbiology & infectious diseases | 2024

von Bianco, G. | Boattini, M. | Comini, S. | +3

6

Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021

enthalten in: Microbial drug resistance (Larchmont, N.Y.) | 2024

von Amadesi, S. | Palombo, M. | Bovo, F. | +6

7

In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Palombo, M. | Secci, B. | Bovo, F. | +3

8

In vitro activity of cefiderocol in combination with new β-lactam/β-lactamase inhibitor combinations (βL-βLICs) against multidrug resistant KPC-producing Klebsiella pneumoniae

enthalten in: The Journal of antibiotics | 2023

von Gaibani, P. | Lazzarotto, T. | Viale, P. | +1

9

A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia

enthalten in: International journal of antimicrobial agents | 2023

von Gatti, M. | Rinaldi, M. | Gaibani, P. | +4

10

Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Gatti, M. | Rinaldi, M. | Bonazzetti, C. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]